In conclusion, up-regulation of IL1B, NLRP3, CASP1 and increased IL-1β concentration suggest the activation of NLRP3 inflammasome in the systemic compartment of patients with stable COPD. This evidence concerns the gene NLRP3 and chronic obstructive pulmonary disease.